摘要
囊性纤维化(CF)主要是由蛋白质错误折叠和一个称为囊性纤维化跨膜传导调节(CFTR)的质膜阴离子通道功能的丧失所引起的。最常见的致突变基因,F508del,其导致CFTR严重的构象缺陷。细胞伴侣机械对CFTR的生物合成和质量控制起着的重要作用。通过调节的细胞分子伴侣机械零部件的表达来提高突变的CFTR细胞表面表达功能,这已进行了多次尝试。由于F508del CFTR缺陷导致严重的内在的折叠,这种方法的有效性在很大程度上被低估。此外,伴侣机械本身的伴侣扰动和其他生理上的重要蛋白的影响,可能会导致潜在的严重副作用。针对扰乱伴侣-CFTR相互作用的方法表现出更大的效能,并能兼容小分子药物的发现和基因治疗。针对扰乱伴侣-CFTR相互作用的方法表现出更大的效能,并能兼容小分子药物的发现和基因治疗。分子伴侣在调节炎症和免疫中发挥重要作用,它们可能是控制患者的呼吸道感染和炎症的潜在靶标。如果这种影响可以通过协同分子伴侣介导的CFTR的生物合成和质量控制增效,那么将会有更有效的新治疗CF肺病方案出现。
关键词: 囊性纤维化跨膜电导调节因子(CFTR),囊性纤维化,药物发现,F508del,免疫,炎症,分子伴侣,蛋白质折叠
图形摘要
Current Drug Targets
Title:Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?
Volume: 16 Issue: 9
Author(s): Ashley Heard, Jake Thompson, Jessica Carver, Michelle Bakey and X. Robert Wang
Affiliation:
关键词: 囊性纤维化跨膜电导调节因子(CFTR),囊性纤维化,药物发现,F508del,免疫,炎症,分子伴侣,蛋白质折叠
摘要: Cystic Fibrosis (CF) is largely caused by protein misfolding and the loss of function of a plasma membrane anion channel known as the cystic fibrosis transmembrane conductance regulator (CFTR). The most common CF-causing mutation, F508del, leads to severe conformational defect in CFTR. The cellular chaperone machinery plays an important role in CFTR biogenesis and quality control. Multiple attempts have been made to improve the cell surface functional expression of the mutant CFTR by modulating the expression of components of the cellular chaperone machinery. The efficacy of such an approach has been low largely due to the severe intrinsic folding defects of the F508del CFTR. Moreover, the impact of chaperone perturbation on the chaperone machinery itself and on other physiologically important proteins might lead to potentially severe side effects. Approaches aimed at disrupting chaperone-CFTR interactions show greater efficacy, and are compatible with small-molecule drug discovery and gene therapy. Combination between chaperone modulators and F508del correctors might further enhance potency and specificity. As molecular chaperones play important roles in regulating inflammation and immunity, they can be potential targets for controlling airway infection and inflammation in patients. If such effects can be synergized with chaperone-mediated regulation of CFTR biogenesis and quality control, more efficacious therapeutics will be developed to combat CF lung disease.
Export Options
About this article
Cite this article as:
Ashley Heard, Jake Thompson, Jessica Carver, Michelle Bakey and X. Robert Wang , Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?, Current Drug Targets 2015; 16 (9) . https://dx.doi.org/10.2174/1389450116666150518102831
DOI https://dx.doi.org/10.2174/1389450116666150518102831 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry Glycomics: Relevance for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Properties of Cell Sources in Tissue-Engineered Three-dimensional Oral Mucosa Model: A Review
Current Stem Cell Research & Therapy Bioactive Proteins and Peptides from Food Sources. Applications of Bioprocesses used in Isolation and Recovery
Current Pharmaceutical Design Treatment of Chronic Hepatitis B in Children
Recent Patents on Anti-Infective Drug Discovery Muscle Atrophy Classification: The Need for a Pathway-Driven Approach
Current Pharmaceutical Design Pentoxifylline and Local Honey for Radiation-Induced Burn Following Breast Conservative Surgery
Current Clinical Pharmacology Polymer Drug Conjugates: Recent Advancements in Various Diseases
Current Pharmaceutical Design Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Subject index to volume 3
Current Molecular Medicine Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Vital Tooth Whitening Techniques. A Literature Review
Current Dentistry Editorial [Hot Topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Hypertension-Related Disorders (Executive Guest Editor: Aurelio Leone)]
Current Pharmaceutical Design NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
Current Medicinal Chemistry A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
Current Drug Metabolism Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Good Practice in Umbilical Cord Blood Collection in Order to Identify Suitable Units Before Cryopreservation
Letters in Drug Design & Discovery The INSL3-LGR8 Hormonal System in Humans: Testicular Descent, Cryptorchidism and Testicular Functions
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry Current Progress in Molecular Responses to Acidosis in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents